DMK
Barclays’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,347
| Closed | -$8K | – | 3921 |
|
|
2021
Q3 | $8K | Buy |
7,347
+1,824
| +33% | +$1.99K | ﹤0.01% | 3785 |
|
|
2021
Q2 | $6K | Sell |
5,523
-26,131
| -83% | -$28.4K | ﹤0.01% | 3954 |
|
|
2021
Q1 | $30K | Buy |
+31,654
| New | +$30K | ﹤0.01% | 3599 |
|
|
2019
Q4 | – | Sell |
-109
| Closed | – | – | 4321 |
|
|
2019
Q3 | $0 | Buy |
+109
| New | – | ﹤0.01% | 4496 |
|
|
2019
Q2 | – | Sell |
-172,557
| Closed | -$364K | – | 4493 |
|
|
2019
Q1 | $364K | Buy |
172,557
+123,857
| +254% | +$261K | ﹤0.01% | 2758 |
|
|
2018
Q4 | $110K | Buy |
+48,700
| New | +$110K | ﹤0.01% | 2946 |
|
|
2018
Q2 | – | Sell |
-1,700
| Closed | -$6K | – | 4448 |
|
|
2018
Q1 | $6K | Sell |
1,700
-104,341
| -98% | -$368K | ﹤0.01% | 4009 |
|
|
2017
Q4 | $466K | Buy |
+106,041
| New | +$466K | ﹤0.01% | 2132 |
|
|
2016
Q3 | – | Sell |
-2,845
| Closed | -$8K | – | 4098 |
|
|
2016
Q2 | $8K | Buy |
+2,845
| New | +$8K | ﹤0.01% | 3046 |
|